News
Charting the Future of Neuroendocrine Cancer Research: The NETRF Research Roadmap
At the Neuroendocrine Tumor Research Foundation (NETRF), we are dedicated to transforming the future of neuroendocrine cancer care. As the world’s leading funder of neuroendocrine
Sharing Knowledge, Driving Change: Highlights from the INCA Summit
By Elyse Gellerman, CEO Representatives from 25 neuroendocrine cancer advocacy groups gathered earlier this month in Sofia, Bulgaria, for the 13th INCA (International Neuroendocrine Cancer
Neuroendocrine Cancer on the Rise: What the Latest Research Shows
By Anna Greene, PhD, NETRF Director of Research A major new study published in JAMA Network Open by Arvind Dasari, MD, MS, and colleagues provides
A New Consensus: Shedding Light on NET G3 Care
By Anna Greene, PhD, NETRF Director of Research We’re excited to share insights from a new ENETS (European Neuroendocrine Tumor Society) position statement, published in
NETRF Fosters Learning and Community in Birmingham
By Anne-Marie Green, NETRF Director of Digital Communications NETRF brought the NET Impact Thrivership & Research Education Program to Alabama for the first time on
A New Genetic Clue to Aggressive Pancreatic Neuroendocrine Tumors
By Anna Greene, PhD, NETRF Director of Research Pancreatic neuroendocrine tumors (PanNETs) are rare and tricky. Some grow slowly and never cause trouble, while others
Educated and Empowered: Barbara Dunham’s Neuroendocrine Cancer Journey
By Anne-Marie Green, Director of Digital Communications As a 19-year veteran educator, Dr. Barbara Dunham’s learning instincts were set in motion when she was diagnosed
How Recent Tax Law Changes Impact Your Charitable Giving
Congress recently passed new tax legislation that will change how charitable contributions are treated starting in 2026. While the bill is complex, we want to
NETRF 2025 BTSI Awardee Spotlight: Advancing GEP-NET Research with Suzann Duan, PhD
We’re proud to celebrate Dr. Suzann Duan, an Assistant Professor in the Department of Pharmaceutical Sciences at UC Irvine, as the recipient of the 2025 Basic/Translational
Expanding the Frontier of Neuroendocrine Tumor Imaging
By Anna Greene, PhD, NETRF Director of Research Dr. Benjamin Viglianti, recipient of a 2023 NETRF Investigator Award, is the senior author of a newly